INFLUENZA IMMUNIZATION

This study tested a single combination shot that aims to protect against both COVID-19 and the flu. About 980 adults aged 50 and older received either the combo vaccine, each vaccine alone, or a placebo. Researchers checked for side effects and measured immune responses over 12 m…

This early-stage study tested a new mRNA-based flu vaccine in 159 adults aged 18-49 and 60+. The goal was to check safety and how well the vaccine triggers an immune response compared to a standard flu shot. Researchers looked for side effects and measured antibody levels in the …

This early-stage study tested a new mRNA-based flu vaccine in 233 healthy adults aged 18 and older. The goal was to check if the vaccine is safe and triggers an immune response. Participants received one shot at different dose levels, and researchers monitored side effects and an…

This study tested a new combination vaccine that aims to protect against both COVID-19 and the flu with a single shot. It involved about 980 adults aged 50 and older in the United States. The main goal was to see if the combo vaccine is safe and triggers a strong immune response …

This study tested a new mRNA vaccine designed to protect against a potential pandemic flu caused by the H5 strain. 276 healthy adults aged 18 and older received either a low, medium, or high dose of the vaccine or a placebo. The main goal was to check safety and see how well the …

This study looked at whether it's safe and effective to give a high-dose flu vaccine and a Moderna COVID-19 booster at the same time to adults aged 65 and older. Participants had already received two doses of the Moderna COVID-19 vaccine at least five months earlier. The goal was…

This study tested a high-dose flu vaccine in 1,539 healthy adults aged 60 and older. The goal was to see if the high-dose shot triggers a stronger immune response than the standard-dose flu shot. Results showed that the high-dose vaccine produced higher antibody levels against al…

This study tested a new type of flu vaccine in 1308 people aged 9 to 49. The goal was to see if the vaccine works as well in children and teens as it does in adults. Researchers measured immune responses and checked for safety after one dose.

This study tested whether a high-dose flu vaccine (QIV-HD) works better than the standard-dose vaccine (QIV-SD) in adults aged 60 and older. About 2,100 healthy volunteers in Japan received one of the two vaccines. The goal was to see if the high-dose version triggers a stronger …

This study collected blood samples from 90 healthy children (6 months to under 9 years) and adults 65 and older who received the 2020-2021 flu vaccine. The samples were sent to health experts to help decide which flu strains to include in future vaccines. The goal was to support …

This study surveyed about 5,000 adults in Germany to find out how many people got their flu shot during the respiratory season. It focused on adults aged 60 and older, as well as those with chronic health conditions. The goal was to provide up-to-date information to help public h…

This study collected blood samples from 90 healthy children (6 months to under 9 years) and older adults (65+) after they received their regular flu shots. The samples were sent to health agencies to help decide which flu strains to include in future vaccines. No new treatment or…

This study asked over 1,000 adults in the U.S. about their experience after receiving a trivalent recombinant flu vaccine. Participants completed a 30-minute online survey about side effects, pain, and how the shot affected their daily life. The goal was to better understand vacc…